Grants and Contributions:
Title:
Artificial intelligence-based compound screening system for drug discovery
Agreement Number:
933368
Agreement Value:
$45,820.00
Agreement Date:
Sep 1, 2019 - Mar 31, 2020
Description:
The inaccuracy of the available computational methods limits the success rate of structure-based in silico drug screening. By taking advantage of abundant experimental data and state-of-the-art artificial intelligence technologies, we are developing a system which overcomes the weaknesses of current screening methods.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Vancouver, British Columbia, CA V6T 1W5
Reference Number:
172-2019-2020-Q2-933368
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
766039887
Recipient Type:
For-profit organization
Recipient's Legal Name:
Pharmasilico Technologies Inc.
Federal Riding Name:
Vancouver Quadra
Federal Riding Number:
59039
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
541710